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Abstract!"
To improve in vitro cell cultures, bioreactor systems have been widely used, 
e.g. in bone tissue engineering. Spinner flasks, rotating wall bioreactors, and 
flow perfusion systems have all been used, and each system has 
advantages and disadvantages. This thesis describes the development of a 
simple perfusion bioreactor system and the results from the assessment 
methodology employed which is based on x-ray µCT analysis and 3D 
Modeling Techniques.  "
A simple bioreactor with flow generator propeller was designed and built with 
the aim of improving differentiation of human embryonic derived 
mesenchymal stem cells (hES-MP) seeded on porous titanium scaffolds in 
order to improve mineralized matrix deposition. The bioreactor allows three 
types of flow: forward (clockwise), backward (counterclockwise) and pulse 
mode (back and forth) controlled by a micro-controller and a graphical 
interface. "
We designed a simple model to calculate the pressure generated by the flow 
of the bioreactor on the scaffold (3•10-2 Pa). "
We compared 3 scaffolds under static culture condition to 3 scaffolds within 
the bioreactor. The scaffolds were incubated for 21 days, fixed in 
paraformaldehyde (4% w/v) and subjected to acquisition by x-ray μCT."
Images obtained were processed using 3D imaging software; a “virtual" 
sectioning of the scaffolds was performed in order to obtain samples 
extracted from the surface and from the inside of the scaffolds in order to 
obtain the gray value gradient distribution. "
This distribution is used to distinguish the various components present in the 
images, in this case scaffolds from the hypothetical cellular matrix."
The results show that scaffolds maintained in the bioreactor have higher 
density of gray values gradient distribution on the scaffold surface which 
suggests improved mineralized matrix deposition.!
The studies coming from this bioreactor will be used to design a new version 
that will make it possible to analyze more than 20 scaffolds at the same time 
making it possible to further analyze the quality of the differentiation using 
molecular and histochemical methodology."
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Abstract!"
Al fine di migliorare le tecniche di coltura cellulare in vitro, sistemi a 
bioreattore sono sempre maggiormente utilizzati, e.g. ingegnerizzazione del 
tessuto osseo. Spinner Flasks, bioreattori rotanti e sistemi a perfusione di 
flusso sono oggi utilizzati e ogni sistema ha vantaggi e svantaggi. "
Questo lavoro descrive lo sviluppo di un semplice bioreattore a perfusione 
ed i risultati della metodologia di valutazione impiegata, basata su analisi 
μCT a raggi-X e tecniche di modellizzazione 3D."
Un semplice bioreattore con generatore di flusso ad elica è stato progettato 
e costruito con l'obiettivo di migliorare la differenziazione di cellule staminali 
mesenchimali, provenienti da embrioni umani (HES-MP); le cellule sono 
state seminate su scaffold porosi di titanio che garantiscono una migliore 
adesione della matrice mineralizzata. Attraverso un microcontrollore e 
un'interfaccia grafica, il bioreattore genera tre tipi di flusso: in avanti (senso 
orario), indietro (senso antiorario) e una modalità a impulsi (avanti e 
indietro)."
Un semplice modello è stato realizzato per stimare la pressione generata dal 
flusso negli scaffolds (3•10-2 Pa). "
Sono stati comparati tre scaffolds in coltura statica e tre all’interno del 
bioreattore. Questi sono stati incubati per 21 giorni, fissati in 
paraformaldehyde (4% w/v) e sono stati soggetti ad acquisizione attraverso 
μCT a raggi-X. "
Le immagini ottenute sono state poi elaborate mediante un software di 
imaging 3D; è stato effettuato un sezionamento “virtuale” degli scaffolds, al 
fine di ottenere la distribuzione del gradiente dei valori di grigio di campioni 
estratti dalla superficie e dall’interno di essi."
Tale distribuzione serve per distinguere le varie componenti presenti nelle 
immagini; in questo caso gli scaffolds dall’ipotetica matrice cellulare. "
I risultati mostrano che sia sulla superficie che internamente agli scaffolds, 
mantenuti nel bioreattore, è presente una maggiore densità dei gradienti dei 
valori di grigio ciò suggerisce un migliore deposito della matrice 
mineralizzata.!
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Gli insegnamenti provenienti dalla realizzazione di questo bioreattore 
saranno utilizzati per progettare una nuova versione che renderà possibile 
l’analisi di più di 20 scaffolds contemporaneamente, permettendo un’ulteriore 
analisi della qualità della differenziazione usando metodologie molecolari ed 
istochimiche."
""""""""""""""""""""""""""""""""""""""""""""""
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1. Introduction!"
Tissue Engineering (TE) is a discipline integrating biology with engineering 
to create tissues or cellular products outside the body (ex vivo) or to make 
use of gained knowledge to better manage the repair of tissues within the 
body (in vivo). This discipline requires understanding of different biological 
fields, including cell and molecular biology, physiology and systems 
integration, stem cell proliferation and differentiation with lineage attributes, 
extracellular matrix chemistry and compounds, and endocrinology. It also 
requires knowledge of many engineering fields, including biochemical and 
mechanical engineering, polymer sciences, bioreactor design and 
application, mass transfer analysis of gas and liquid metabolites, and 
biomaterials. "
The combination of these sciences has spawned the field of regenerative 
medicine which has, at present, two strategic clinical aims [1]: "
"
• Cell therapies for the repair of damaged tissues, involving injection or 
engraftment of cells or cellular suspensions, sometimes in combination 
with scaffolding material"
"
• Establishment of tissue ex vivo for use as grafts or extracorporeal organs 
to assist or supplement ailing in vivo organs"
"
Tissue Engineering has been defined first as “an interdisciplinary field that 
applies the principles of engineering and the life sciences toward the 
development of biological substitutes that restore, maintain, or improve 
tissue function” [2]. Another definition is “understanding the principles of 
tissue growth, and applying this to produce functional replacement tissue for 
clinical use” [3]. "
Thus, Tissue Engineering has always been driven by the need to provide 
functional equivalents of native tissues that can be used for in vivo 
implantation in order to restore, maintain, or enhance tissue and organ 
physiology. To engineer living tissues, cultured cells are coaxed to grow on 
bioactive degradable scaffolds that provide the physical and chemical cues 
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to guide their differentiation and assembly into two- or three-dimensional 
tissues [4]. In contrast to classic biomaterial approach, it is based on the 
understanding of tissue formation and regeneration, and aims to induce new 
functional tissues, rather than just to implant new spare parts [5]."
"
Tissue Engineering seeks to rebuild portions of tissue or whole organs 
through the manipulation of cells, using a wide variety of strategies [6]. 
These mainly involve the use of synthetic scaffolds, fabricated from 
biocompatible materials, to carry, support and guide cells towards tissue 
regeneration. The field of scaffold construction is still in its infancy, and many 
different approaches, both general and specific, are under investigation. Of 
particular interest is the ability to mimic the natural extracellular matrix 
surrounding cells in each tissue. Tissue specific functionality is largely 
maintained through the interaction of cells with matrix biological ligands, 
mechanical support and structural interaction. Matrix structure is particularly 
important for determining the flow of nutrients, signaling factors and waste 
products about cells, influencing their motility, protein expression and long-
term differentiation [7]. In many cases it would be desirable to replace both 
small and large areas of diseased and damaged tissue with new healthy 
tissue, either fully generated outside the body, or at the site of damage 
through use of scaffolds engineered to support and encourage new tissue 
genesis. The scaffold must provide both the mechanical properties required 
by the regenerating tissue as well as the cues that cells require. This is a 
complex challenge. The organs of the body are highly sophisticated 
biological systems. Each maintains their own unique set of biological 
conditions, needed to sustain the function of tissue specific cells and enable 
self repair. These environments are difficult to mimic outside the body. One 
approach is to use the body as its own incubator, [8] drawing directly on the 
complexity of natural tissues to enable the generation of new tissue. For 
example an osteoconductive gel injected into the stem cell rich periostium 
layer in bone was used to create a space for the generation of new bone 
tissue, suitable for re‐implantation [9]. Another approach is to use scaffolds 
that provide an appropriately sophisticated representation of the tissue 
environment, encouraging cells to generate new tissue (Figure 1) as the 
scaffold degrades"
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"
! "
Figure 1 - The typical tissue engineering approach: 1. Remove cells; 2. Expand number in 
culture; 3. Seed onto an appropriate scaffold with suitable growth factors and cytokines; 4. 
Place into culture; 5. Re-implant engineered tissue repair damaged site [7]""
There are three principal strategies for treating diseased or lost tissue in 
patients [10]: "
"
• In situ tissue regeneration: new tissue formation is induced by specific 
scaffolds or external stimuli that are used to stimulate the body‘s own cells 
and promote local tissue repair"
"
• Implantation of freshly isolated or cultured cells: individual cells or small 
cellular aggregates from the patient or a donor are injected directly into the 
damaged or lost region with a degradable scaffold"
"
• Implantation of bone like tissue assembled in vitro from cells and scaffold: 
a complete three-dimensional tissue is grown in vitro using autologous or 
donor cells within a scaffold, which has to be implanted once it has 
reached “maturity”"
"
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Bone tissue engineering, as in most other Tissue Engineering areas, exploits 
living cells in a variety of ways to restore, maintain, or enhance tissue 
functions. The basic elements for tissue engineered bone are signaling 
molecules, cells and matrices for cell growth and differentiation. The 
combination of these three elements may need to be modified according to 
several variables such as patient age, gender, health, systemic conditions, 
habits, and anatomical shape of the implant. Furthermore that same strategy 
should also adapt itself to the area where the tissue engineering construct is 
needed, because different regions of the body will have different functional 
loads and vascularity. Up to now several strategies, from scaffolds alone to 
3D matrices loaded with growth factors, have been proposed [5]. "
"
"
1.1 Stem Cell "
Bioreactors utilize materials and cells that have already been proven 
effective for bone tissue engineering including polymer scaffolds that are 
biodegradable and mesenchymal stem cells (MSCs), a population of cells 
that exists in the bone marrow capable of differentiating into osteoblasts, 
chondrocytes, and adipocytes [11, 12]. This population represents only a 
small percentage of cells found in the bone marrow, thus expanding MSCs 
to clinically relevant numbers represents a significant hurdle to the 
implementation of a tissue engineering strategy utilizing these cells."
"
Stem cells are undifferentiated cells with a high proliferation capability, being 
able of self- renewal, multilineage differentiation and therefore the 
regeneration of tissues [5]. However, stem cells have varying degrees of 
differentiation potential. The most primitive derive from the fertilized oocyte 
(the zygote), more precisely from the very first descendants of the first 
divisions (two divisions). These cells are totipotent, because they are able to 
form the embryo and the trophoblast of the placenta. Some days later, these 
cells start to specialize, forming a hollow ball of cells, the blastocyst, and a 
cluster of cells called the Inner Cell Mass (ICM) from which the embryo 
derives. The ICM cells, also known as embryonic stem cells (ES), are 
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considered to be pluripotent (Figure 2). They can differentiate in almost all 
cells that arise from the three germ lines, but not the embryo because they 
are not able to give rise to the placenta and supporting tissues [13 ,14]."
"
! ""
Figure 2 - Early development of embryo. Division of the fertilized egg results in the formation 
of a ball-like structure with a cavity on one end (the blastula). Until this stage, the cells divide 
by symmetric division, and all cells produced are totipotent. Invagination of one pole of the 
blastula leads to formation of the gastrula and establishment of the primitive germinal cell 
layers. During gastrulation and later formation of the fetus, the daughter cells lose potential 
as they gain specialized function. The process of the loss of potential and the gain of 
specialized function is known as determination [15].""
Finally, we can find multipotent stem cells, also known as adult stem cells 
(ASC), in the fully differentiated tissues [13, 14, 16]. Theoretically, and 
opposing to ES cells, these would only be capable of producing a limited 
range of differentiated progeny, related to the embryonary origin of the tissue 
where they are located [13, 14]. However, these cells may have a higher 
degree of differentiation plasticity (differentiation into other cell lineages that 
are not related with the embryonary origin of the tissue were the ASCs are 
found) than expected. The biological mechanisms responsible by the broad 
developmental potential of stem cells are still not fully understood. 
Interaction with other cell types and the components of the extracellular 
matrix are believed to influence the survival and the development of stem 
cells to the committed lineages [5, 14, 16]."
Tissue engineering strategies that combine scaffolds with cells capable of 
osteogenesis or bioactive proteins offer a potential alternative to bone 
grafting for treatment of large, clinically challenging bone defects. Several 
studies have demonstrated that delivery of osteoprogenitor cells or 
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osteoblasts significantly improves repair of long bone and cranial defects 
[17]. Tissue engineering has become a popular field of research for the 
treatment of many medical conditions. Strategies in tissue engineering for 
orthopedic disorders including those of bone, cartilage and muscle have 
been intensively studied. Stem cells are particularly attractive for TE 
applications due to their ability to self-renew, high proliferation capacity and 
ability to differentiate into many different cell types [18]."
"
"
1.2 Scaffold "
Scaffolds for tissue regeneration are defined as: “three dimensional open-
cell porous structures synthesized from either natural or synthetic polymers 
which have the potential to support attachment, migration and multiplication 
of living cells”. These structural mimics of the extracellular matrix can be 
made of biodegradable synthetic polymers (e.g. polylactic and polyglycolic 
acid) or natural polymers (e.g. collagen, collagen– glycosaminoglycan 
copolymer). It has been demonstrated that scaffold pore size and shape, 
porosity, specific surface area, biodegradability and stiffness significantly 
influence cell functions. To control these features, various fabrication 
techniques have been developed for different biomaterials [19]."
For bone tissue engineering, a wide choice of scaffold materials, including 
metals, natural and synthetic polymers, and ceramics has been proposed, 
each of them presenting different mechanical, chemical, and biological 
characteristics. Particular attention has been given to the manufacturing of 
porous bioceramics that mimic trabecular bone chemistry and structure. 
Calcium phosphate (CaP), hydroxyapatite (HA) ceramics and Porous 
Titanium (Ti) are considered among the most promising bone substitute for 
their bone-like chemical composition and mechanical properties [20]."
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!  
Figure 3. Represents 4 types of biocompatible scaffolds which are used in tissue 
engineering. A) Bioglass is bioactive glass; B) Calcium phosphate scaffold (CaP); C) Open-
cell polylactic acid (OPLA); D) Titanium scaffold [21]"
"
"
1.2.1 Temporary Matrices for Bone Growth!"
Scaffolds are temporary matrices for bone growth and provide a specific 
environment and architecture for tissue development [22]. Any tissue 
consists of a matrix and one, or usually, many cell types. The matrix is, in 
vivo, a 3D scaffold for cells, and provides them with a tissue specific 
environment and architecture. Furthermore, it serves as a reservoir of water, 
nutrients, cytokines, and growth factors. In this sense, and in order to restore 
function or regenerate tissues one needs a template, a scaffold that will act 
as a temporary matrix for cell proliferation and extracellular matrix 
deposition, with consequent bone in-growth until the new bony tissue is 
totally restored/regenerated. Moreover, would also act as a template for the 
vascularization of this neo-tissue and they could actively participate in the 
regenerative process through the release of growth/differentiation factors, 
present in its structure. It is then logical to say that an appropriate 3D 
scaffold is an essential component for a tissue engineering strategy [5]. 
However, it is important to realize that the latter must have a series of 
properties that make it suitable for TE purposes. Besides the choice of 
adequate materials the macro and micro-structural properties of the 
materials are of utmost importance. Such properties effect not only cell 
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survival, signaling, growth, propagation, and reorganization but also their 
gene expression and the preservation, or not, of their phenotype [5]. An 
optimal scaffold for tissue engineering application would mimic the properties 
of the extracellular matrix (ECM) of those tissues to be regenerated perfectly 
and completely [23]."
"
1.2.2 Essential Properties!"
The following properties have been defined has being essential:"
"
• Biocompatibility!
Scaffolds should be well integrated in the host‘s tissue without eliciting an 
immune response [5]."
"
• Porosity!
Scaffolds must posses an open pore, fully interconnected geometry in a 
highly porous structure with large surface to area volume ratios that will allow 
cell in-growth and an accurate cell distribution throughout the porous 
structure, and will facilitate the neovascularization of the construct from the 
surrounding tissue. Furthermore, the scaffolds should also exhibit adequate 
microposity, in order to allow capillary in-growth. Porosity and 
interconnectivity are also important for an accurate diffusion of nutrients and 
gases and for the removal of metabolic waste resulting from the activity of 
the cells that had meanwhile grown into the scaffold. This is of particular 
importance regarding bone tissue engineering because, due to bone 
metabolic characteristics, high rates of mass transfer are expected to occur, 
even under in vitro culture conditions. However, the degree of porosity 
always influences other properties of the scaffolds such as its mechanical 
stability, so, its value, should always be balanced with the mechanical needs 
of the particular tissue that is going to be replaced [5, 24]."
"
"
"
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• Pore Size!
Pore size is also a very important issue because, if the pores employed are 
too small, pore occlusion by the cells will happen. This will prevent cellular 
penetration, extracellular matrix production, and neovascularization of the 
inner areas of the scaffold. It is well accepted that for bone tissue 
engineering purposes, pore size should be within the 200–900 mm range. 
However, Holly et al. [25] reported a different concept. In the referred case 
the authors believe that bone reconstruction will only be achieved by having 
a 3D temporary matrix with a large macro-porous interconnected structure 
with pore size ranging from 1.2-2.0 mm. This later approach has evident 
advantages due to its high surface to volume ratios that will facilitate cell, 
tissue and blood vessels in-growth. However, this affects the mechanical 
properties avoiding its use in areas which are very demanding from the 
mechanical point of view [5]."
"
• Surface Properties!
Surface properties, both chemical and topographical, can control and affect 
cellular adhesion and proliferation. Chemical properties are related with the 
ability of cells to adhere to the material as well as with the protein 
interactions with the latter. Topographical properties are of particular interest 
when the topic is osteoconduction. As defined by Davies et al. [26] 
osteoconduction is the process by which osteogenic cells migrate to the 
surface of the scaffold trough a fibrin clot, which is established right after the 
material implantation. This migration of osteogenic cells trough the clot will 
cause retraction of the temporary fibrin matrix. Hence, it is of the utmost 
importance that the fibrin matrix is well secured to the scaffold or, otherwise, 
when osteogenic cells start to migrate the fibrin will detach from the scaffolds 
due to wound contraction. It has been previously shown [27, 28] that a more 
“rough‘‘ surface will be able to imprison the fibrin matrix, better than a 
smooth surface, and hence facilitate the migration of osteogenic cells to the 
materials surface."
"
"
"
"
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• Osteoinductivity!
Osteoinduction is the process by which stem and osteoprogenitor cells are 
recruited to a bone healing site, and stimulated to undergo the osteogenic 
differentiation pathway. However, when the portion of bone to regenerate is 
large, natural osteoinduction combined with a biodegradable scaffold may be 
not enough. Because of this the scaffold should be osteoinductive by itself 
[5, 29]."
"
"
1.2.3 Mechanical Properties and Biodegradability!"
In vitro, the scaffolds should have sufficient mechanical strength to withstand 
the hydrostatic pressures and to maintain the spaces required for cell in-
growth and matrix production. In vivo, and because bone is always under 
continuous stress, the mechanical properties of the implanted construct 
should ideally match those of living bone, so that an early mobilization of the 
injured site can be made possible. Furthermore, the scaffolds degradation 
rate must be tuned appropriately with the growth rate of the neotissue, in 
such a way that by the time the injury site is totally regenerated the scaffold 
is totally degraded [5, 30]."
"
"
1.2.4 Biomaterials used as Scaffolds!"
The selection of the most appropriate material to produce a scaffold to be 
used in bone tissue engineering applications is a very important step 
towards the construction of a tissue engineered product, since its properties 
will determine, to a great extent, the properties of the scaffold. Up to now 
several materials such as metals, ceramics and polymers from both natural 
or synthetic origins have been proposed [5]."
However, metals and most of the ceramics are not biodegradable, which 
leaves the researcher‘s choice reduced to a small number of ceramics and 
to biodegradable polymers. Ceramics have been widely used in the 
biomedical engineering and bone substitution/regeneration field. They can 
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be from natural (e.g., coralline hydroxylapatite (HA)) origin or synthetic such 
as synthetic HA or b-tricalcium phosphate (b-TCP). Due to interesting 
properties, mainly the fact of being osteoconductive and osteoinductive, 
have been considered for bone tissue engineering applications [5]. Several 
works [5, 31–41] have shown that by using ceramics with or without bone 
marrow cells, good results regarding bone regeneration could be obtained. 
However, these materials have some major drawbacks."
To begin, ceramics materials are brittle and present a low mechanical 
stability, which prevents their use in the regeneration of large bone defects. 
Furthermore, due to factors that happen in vivo, such as osteoclastic activity, 
their degradation/dissolution rates are difficult to predict. This could present 
a problem because if degrades too fast will compromise the mechanical 
stability of the construct, which is low by itself. At the same time, this would 
dramatically increase the extracellular concentrations of Ca and P, which can 
cause cellular death, as demonstrated by Adams et al. [42]."
As an alternative to the above referred materials, there are biodegradable 
polymers, which are believed to be the ideal materials for bone TE. These 
can be divided in two groups: natural and synthetic. 
Natural biodegradable polymers are those obtained from natural sources, 
either from animal or vegetal source. Within these we can find, among 
others, collagen, fibrinogen, chitosan, starch, hyaluronic acid, and 
poly(hydroxybutyrate). The main advantages of these materials are their low 
immunogenic potential, the potential bioactive behavior and the capability of 
interacting with the host‘s tissue, chemical versatility, and in some cases 
their source, as in starch and chitosan, which is almost unlimited [5]."
Synthetic biodegradable polymers are the ones that are more commonly 
used within the biomedical engineering field. Their chemical versatility and 
processability varies according to their structure and nature, and hence a 
direct comparison with the natural polymers can not be established. The 
most widely used are poly(a-hydroxy acids), poly(e-caprolactone), 
poly(propylene fumarates), poly(carbonates), poly-(phosphazenes), and 
poly(anhydrides) [5]."
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1.2.5 Processing Techniques!"
The next step after selecting the adequate materials is to develop or choose 
an adequate processing technique. In order to do so, and to be sure that all 
the scaffolds characteristics are fulfilled, the chosen processing technique 
should obey, in general terms, to the following criteria:"
"
" ." 1) The processing methodology must not adversely affect the          
materials properties, namely their biocompatibility or chemical 
properties. "
" ." 2) The technique should be accurate and consistent, regarding          
porosity, pore size, pore distribution and interconnectivity. "
 " ." 3) Different scaffold batches should exhibit minimal variations in their         
properties when processed from the same set of processing 
parameters and conditions [5]. "
Through the years a series of processing techniques such as solvent 
casting, phase inversion, fiber bonding, melt based technologies, high 
pressure based methods, freeze drying, and rapid prototyping technologies 
were developed with the aim of producing scaffolds with adequate properties 
for bone tissue engineering [5, 43-46]. These techniques typically produce 
stochastically ordered pores and have been used to engineer a variety of 
tissues. Manual intervention, inconsistent and inflexible processing 
procedures, use of toxic organic solvents, use of porogens, shape limitations 
and irreproducibility are the main limitations of these techniques [47]."
"
"
1.2.6 Scaffold Coating!"
Current interest in regenerative medicine is focused on the three 
dimensional tissue formation through the interplay of biomaterials and cells. 
By using scaffolds, cells can be guided to grow into a certain three 
dimensional shape based on the shape of the scaffolds."
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Titanium implants are commonly used in orthopedics today e.g. dental and 
hip implants. The problem of implant loosening with time and poor 
integration with the surrounding bone tissue has lead to experiments where 
cells are cultured on titanium surfaces in attempts to improve implant 
integration."
Coating porous titanium scaffolds with fibronectin, is an important step for 
better cell attachment after subsequent cell seeding."
Fibronectin (FN) is a multifunctional, extracellular matrix glycoprotein 
composed of two nearly identical disulfide-bound polypeptides of molecular 
weight 220 kDa. Cellular fibronectin is structurally and antigenically similar to 
cold insoluble globulin from plasma, therefore polyclonal antibodies to either 
form usually crossreact. "
  "
Figure 4 - Fibronectin, functionally and structurally distinct domain"
"
Careful analysis of the fibronectin molecule indicates that it contains several 
functionally and structurally distinct domains which may bind to cell surfaces, 
collagen, fibrinogen or fibrin, complement, glycosaminoglycans, 
proteoglycans and heparin. Numerous studies have shown that fibronectin 
may enhance cell adhesion and spreading and affect the routes of cell 
migration both in vivo and in culture [48]. Moreover, it has been shown that 
upon malignant transformation many cells lose most of their surface bound 
fibronectin. Fibronectin has been shown to also play a role in cellular 
morphology, cytoskeletal organization, phagocytosis, hemostasis, embryonic 
differentiation and wound repair. Fibronectin is produced by a wide variety of 
epithelial and mesenchymal cells in vitro including: fibroblasts, chondrocytes, 
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1. Purpose 
To coat porous titanium scaffolds with fibronectin for better cell attachment after subsequent 
cell seeding 
2. Principles and background 
Fibronectin (FN) is a 
multifunctional, extracellular 
matrix glycoprotein composed 
of two nearly identical 
disulfidebound polypeptides of 
molecular weight 220 kDa. 
Cellular fibronectin is 
structurally and antigenically 
similar to cold insoluble globulin 
from plasma, therefore 
polyclonal antibodies to either 
form usually crossreact. Careful 
analysis of the fibronectin 
molecule indicate that it contains several functionally and structurally distinct domains which 
may bind to cell surfaces, collagen, fibrinogen or fibrin, complement, glycosaminoglycans, 
proteoglycans and heparin. Numerous studies have shown that fibronectin may enhance cell 
adhesion and spreading and affect the routes of cell migration both in vivo and in culture. 
Moreover, it has been shown that upon malignant transformation many cells lose most of their 
surface bound fibronectin. Fibronectin has been shown to also play a role in cellular morphology, 
cytoskeletal organization, phagocytosis, hemostasis, embryonic differentiation and wound repair. 
Fibronectin is produced by a wide variety of epithelial and mesenchymal cells in vitro including: 
fibroblasts, chondrocytes, myoblasts, Schwann cells, macrophages, hepatocytes and intestinal 
epithelial cells. Cellular fibrone tin is present in ma y tissues including spl en, lymph n de, 
tonsil, blood vessel walls, liver, kidney, muscle, skin, brain and peripheral nerves. It is found in 
basement membranes and in loose connective tissue stroma.  It  is  also  present  in  platelet  α-
granules and is expressed on the platelet surface after activation. 
 
By: George Sitterley, BioFiles 2008, 3.8, 8. - http://www.sigmaaldrich.com/technical-
documents/articles/biofiles/fibronectin.html  
  
Coating porous titanium with fibronectin 
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myoblasts, Schwann cells, macrophages, hepatocytes and intestinal 
epithelial cells. Cellular fibronectin is present in many tissues including 
spleen, lymph node, tonsil, blood vessel walls, liver, kidney, muscle, skin, 
brain and peripheral nerves. It is found in basement membranes and in 
loose connective tissue stroma. It is also present in platelet α- granules and 
is expressed on the platelet surface after activation."
"
1.3 Bioreactor!"
In the overall cell-based bone tissue engineering strategy of expanding a 
stem cell source in vitro, culturing and differentiating this cell source on a 
three-dimensional scaffold, and implanting this scaffold in vivo, bioreactors 
can be used to enhance in vitro culture steps [49]."
"
  "
Figure 5 - Four types of a bioreactor which is used in bone tissue engineering. A) Properties 
of a rotating wall bioreactor; B) Properties of a stirring bioreactor; C) Principle of a perfusion 
bioreactor and D) Compression bioreactor"
"
There have been lot of researches on the bioreactor in the past two 
decades. Lot of varying versions have been made for different kind of 
tissues. The most known bioreactor systems (Figure 5) are: "
"
"
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• Rotating wall system!
Rotating wall system includes a cylindrical chamber which is filled with 
culture media and the scaffolds are moving freely inside. The outer wall of 
the chamber is capable to rotating slowly creating a hydrodynamic 
movement. Due to this drag force of movement the gravity force is neglected 
and the scaffold experience weightlessness inside the chamber. The 
weightlessness encourages the extracellular matrix expansion but do not 
increase cell proliferation [49,50].     "
"
• Spinner flask system!
This system consists of a container and a magnetic stirring system. The 
magnetic stirrer is at the bottom inside the container which is standing on a 
plate. Inside the plate is a circulating magnetic source which rotates the 
stirrer inside the container. The scaffolds are fixed inside the container by a 
needle and the media is moving surround the scaffolds due to a flow in the 
media created be the magnetic stirring system. Due to flow of the media the 
nutrients are transported more inside the scaffold. This kind of stirring 
system increases the cell differentiation and proliferation [49, 50]. "
"
• Perfusion system!
It may consider that the most effective system for bone tissue engineering is 
used by a flow perfusion bioreactor. The main principle of perfusion system 
is to get nutrition to the inside of the scaffold. It is done by a fluid flow 
through the centre of the scaffold. The scaffolds are fixed into a narrow tube 
filled with a culture media and a flow is applied by a pump or a motor driven 
propeller in one direction inside the tube [49, 50]."
"
• Compression and strain system "
"
"
1.4 Morphometric Analysis!"
A revolutionary invention in the field of medical imaging with X-rays occurred 
at the beginning of the 1970s when the first equipment for computed 
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tomography (CT) was developed. This method of imaging avoids several 
important limitations of conventional X-ray radiology. CT avoids the 
superimposition inherent to radiographic imaging of producing slices in the 
third dimension in a non-destructive way with contrast discrimination up to 
1000 times better than that of a conventional radiograph."
MicroCT is similar to conventional CT systems usually employed in medical 
diagnoses and industrial applied research. Unlike these systems, which 
typically have a maximum spatial resolution of about 0.5 mm, advanced μCT 
is capable of achieving a spatial resolution above 0.3 μm, i.e. about three 
orders of magnitude lower. Such a high spatial resolution can be obtained 
only for samples of reduced size i.e. for dimensions in the range of a few 
cubic millimeters. The spatial resolution of the CT image is dependent on the 
number of parallel beam projections and the number of data points in each 
projection. A larger dataset means a more detailed description of the 
depicted object and hence more pixels and of smaller dimensions, i.e. better 
spatial resolution [51]."
The development of high-resolution X-ray computed tomography (μCT) 
started in the early 1980s and has been used extensively to study the 
structure and architecture of bone tissue. Various parameters can be 
calculated with this technique, depending on the computational capability of 
the hardware and software. In addition, micro- CT is basically a 
nondestructive technique."
Researchers have employed μCT in the field of tissue engineering. The 
versatility of μCT has been demonstrated in the evaluation of scaffolds, 
because this single technique is capable of characterizing multiple aspects 
of the scaffolds. MicroCT enables to get three- dimensional (3D) images of 
the internal volume of a sample, and a detailed 3D view of pores at any 
depth. Further, different parameters may be calculated such as porosity, 
surface area to volume ratio, pore size, pore wall thickness, anisotropy, 
cross-sectional area, and permeability. MicroCT has been used for several 
polymer-based scaffolds that hold sufficient intrinsic contrast. For example, 
the internal geometry, pore network, and pore interconnectivity of poly-e-
caprolactone scaffolds have been determined; in addition, the porosity, 
surface area to volume ratio, and interconnectivity of scaffolds made from a 
copolymer of poly ethylene glycol, poly-ecaprolactone, and polylactic acid 
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have been evaluated. Quantification of microarchitectural parameters, 
including volume fraction, density, thickness, spacing, and degree of 
anisotropy, of porous poly (L-lactide-co-DL- lactide) scaffolds with axially 
oriented macroporosity and random microporosity has also been reported. 
Scaffolds based on natural proteins such as collagen do not have the 
intrinsic X-ray attenuation capacity to be imaged by 3D microCT. 
Consequently, additional contrast has to be imposed upon such scaffolds 
[52]. Feldkamp et al. pioneered microCT when he developed an X-ray-based 
microtomographic system to analyze trabecular samples at a spatial 
resolution of 50 mm. Since then, microCT had been used extensively in the 
study of trabecular architecture and there are increasing applications of it in 
other areas. Its popularity can be attributed to its ability to provide precise 
quantitative and qualitative information on the 3D morphology of the 
specimen. The interior of the specimen can be studied in great detail without 
resorting to physical sectioning nor using toxic chemicals. Moreover, after 
scanning, the intact samples can be subjected to other tests, therefore 
resolving the problem of sample scarcity. As researchers began to recognize 
the potential of this radiographic technique, various biomedical applications 
are being explored which would include the assessment of scaffolds, 
regenerated tissue and vasculature networks."
In micro CT scanning, the specimen is divided into a series of 2D slices 
which are irradiated from the edges with X-rays. Upon transversing through 
the slice, the X-rays are attenuated and the emergent X-rays with reduced 
intensities are captured by the detector array. From the detector 
measurements, the X-ray paths are calculated and the attenuation 
coefficients are derived. A 2D pixel map is created from these computations 
and each pixel is denoted by a threshold value which corresponds to the 
attenuation coefficient measured at a similar location within the specimen. 
As the attenuation coefficient correlates to the material density, the resultant 
2D maps reveal the material phases within the specimen. The quality of the 
2D maps is dependent on the scanning resolution which ranges from 1 to 50 
mm. At high resolutions, intricate details are imaged, however more time is 
required for high resolution scanning and the resultant large data set poses 
a challenge for data storage and processing."
"
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  "
Figure 6 - MicroCT technique. In μCT to produce a three-dimensional CT image, a whole set 
of such two dimensional projections need to be acquired. These projections are usually 
taken in a setup in which the source and detector are at a fixed position and the object is 
rotated around its long axis. It can be shown that the number of projections taken over 180 
degrees should be about twice the number of samples per projection to avoid aliasing 
artifacts. The two-dimensional projections can then be used to reconstruct a three- 
dimensional image""
"
1.4.1 Scaffolds 3D Modeling!"
Image thresholding is a crucial step that has to be executed prior to 3D 
modeling and it affects the subsequent analysis and visualization. In the 
conventional approach, the thresholding range is selected via histographics 
and visual estimation and the problem arises when the scaffold composes of 
multiple materials whose thresholding ranges overlap and this renders the 
digital separation of these materials a difficult task. Moreover, as 
polychromatic X-ray beams are used in microCT, the lower energy rays 
would be readily attenuated by the sample resulting in a high exposure at 
the center of the scaffold. This effect is known as beam hardening and as a 
result thresholding is no longer dependent solely on radiodensity but also on 
the specimen size. MicroCT analysis is not suitable for scaffolds containing 
metals as X-rays are heavily attenuated by these metals. The presence of 
metals results in dark and bright grainy artifacts which obscure important 
details in the scan images. As microCT is a relatively new technology, 
improved algorithms and setups are anticipated, thus resolving such imaging 
errors [53]."
"
"
"
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50 mm. At high resolutions, intricate details are imaged, however more time is required for 
high resolution scanning and the resultant large data set poses a challenge for data storage 
and processing.  
 
igure 3-8: MicroCT technique. In µCT to produce a three-dimensional CT image, a 
whole set of such two-dimensional proj cti ns need to be acquired. These projections are 
usually taken in a setup in which the source and detector are at a fixed position and the 
object is rotated around its long axis. It can be shown that the number of projections taken 
over 180 degrees should be about twice the number of samples per projection to avoid 
aliasing artifacts. The two-dimensional projections can then be used to reconstruct a three-
dimensional image. 
 
 
3D modeling programs such as Mimics (Materialize, Belgium), Velocity and Anatomics 
stack the 2D maps to create 3D models, without these programs, visualization and analysis 
would have been impossible. As computation is inherent in this technique, the selection of 
software and hardware facilities would influence the efficiency and effectiveness of this 
radiographical assessment, There are associated concerns despite of the numerous 
advantages of using micro CT. Image thresholding is a crucial step that has to be executed 
prior to 3D modeling and it affects the subsequent analysis and visualization. In the 
conventional approach, the thresholding range is selected via histographics and visual 
estimation and the problem arises when the scaffold composes of multiple materials whose 
thresholding ranges overlap and this renders the d gital separation of th se mate ials a 
difficult task. Moreover, as polychromatic X-ray beams are used in micro CT, the lower 
energy rays would be readily attenuated by the sample resulting in a high exposure at the 
center of the scaffold. This effect is known as beam hardening and as a result thresholding 
is no longer dependent solely on radiodensity but also on the specimen size. Micro CT 
analysis is not suitable for scaffolds containing metals as X-rays are heavily attenuated by 
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2. Materials and Methods!"
2.1 Bioreactor Development!"
In this thesis, a flow perfusion bioreactor was developed from a prototype 
(Figure 7 and Figure 8) made by Department of Science of Landspítali 
University Hospital and  the Institute of Biomedical and Neural Engineering 
of Reykjavík University."
"
  "
Figure 7 - The prototype consists out of one tube and three disks and a container "
  "
Figure 8 - Bioreactor system with the scaffolds. The small holes which are in the disks form 
small tubes."""
"
"
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This device, however, had different aspects to be improved, such as:"
"
• Replacing the DC Motor!
"
The used DC Motor corresponded to the small engines that often found in 
small appliances or toys for children. These motors provided a functioning 
also at low voltages, reduced storage space and limited performance. The 
motor in this prototype (DC Motor 1) had the following characteristics:"
"
The replaced DC Motor (DC Motor 2) had better features instead. In 
particular it was controlled by a microcontroller that allowed to obtain a 
speed value between 0 and 255 svm, where 0 svm was about to 0 rpm and 
255 svm was about to 5700 rpm. "
The DC Motor replacement was necessary because the DC Motor 1 did not 
provide sufficient continuity of working for all 4 weeks of cell culture. To 
investigate the stability were performed two types of tests:"
"
- Operation test over time (2-3 days of test)"
- Operation test real-time (with digital multimeter) "
"
The first test was carried out leaving the bioreactor in operation for 2-3 days, 
in the same operating conditions to be maintained during the cell culture."
The second test was performed by the use of a digital multimeter that has 
allowed to detect in real time the voltages across the DC Motor, in order to 
understand at what speed (rpm), the engine would guarantee the best 
performance. "
For the DC Motor 1, the results were: for the first test, several blocks could 
be resolved only by restarting of operations; for the second test, a working 
speed had to be at least 220 svm."
For the DC Motor 2, the results were: for the first test, no blocking 
detectable; for the second test, a working speed equal to 90 svm, 
guaranteed good performance."
The following table shows the technical characteristics (Table 1) and the 
evaluation of the functioning (Table 2, Figure) of the DC Motor 2"
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Table 1. Data for DC Motor 2"
"
Table 2. Average output values for Forward and Backward Method measured with 
multimeter across the DC Motor 2."
Motor Data
Name Motrax xDrive 2025-22
Rated voltage [V] 1.5
Working voltage [V] 1.5-3.0
No load Revolutions [rpm] 8000
No load Current [A] 0.2
Max load revolutions [rpm] 5700
Max load current [A] 0.5
Max Power [W] 0.24
Max torque [Ncm] 0.04
Efficiency [%] 31.4
Weight [g] 18
Arduino Input 
Values [svm]
Output Values 
Forward [V]
Output Values 
Backward [V]
90 0.36 0.37
100 0.40 0.41
110 0.44 0.45
120 0.48 0.49
130 0.52 0.54
140 0.56 0.58
150 0.60 0.62
160 0.64 0.67
170 0.68 0.71
180 0.72 0.75
190 0.76 0.79
200 0.80 0.84
210 0.83 0.87
220 0.87 0.92
230 0.90 0.96
240 0.94 1.00
255 1.04 1.11
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  "
Figure 9 - The graph, obtained from the values present in the Table 2, show the stability of 
DC Motor 2 "
"
In particular, Table 2 shows that the DC Motor 2 has a greater stability, 
ensuring its operation for the entire period of cell culture, even at low 
speeds."
"
• Replacing the axis and the stabilization system!
"
The axis with propeller, necessary to the realization of the flow inside of the 
bioreactor and the stabilization system (Figure 10) were replaced with a 
steel shaft and a new case of support. This was necessary to avoid 
oscillations and then a non-uniform flow."
"
         "
A                                                          B!
Figure 10 - A) Bioreactor before changes; B) Bioreactor after changes"
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• Creating a plug between the bioreactor and control unit"
"
Finally, it was necessary to create a plug (shown in Figure 10.B) that would 
allow to connect and disconnect the bioreactor from the control unit quickly 
and easily. In particular this addition was very useful during the operations of 
exchange media; in fact it was possible  to disconnect the control unit from 
the bioreactor and to extract only the bioreactor from the incubator without 
having to transport each time also inside the work hood."
"
"
2.1.1 Control Unit!"
The control unit was the heart of the entire bioreactor and thanks to this was 
possible to configure each operation that the bioreactor had to play. It 
consisted of a microcontroller (Arduino UNO) powered via USB transformer 
and required wiring to create various connections (Figure 11)"
"
         "
A                                                                                       B!
Figure 11 - A) Arduino UNO; B) Base with the various connections needed"
"
The Arduino Uno is a microcontroller board based on the ATmega328. It has 
14 digital input/output pins (of which 6 can be used as PWM outputs), 6 
analog inputs, a 16 MHz ceramic resonator, a USB connection, a power 
jack, an ICSP header, and a reset button. "
"
"
"
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Its programming was carried out through two software:"
"
• Arduino "
"
• Processing "
"
“Arduino” is an application that uses the Java programming language and 
allows the implementation of the code realized directly on the 
microcontroller; in this study, this was useful when it was assumed that the 
operating characteristics of a device (e.g., speed, time, program, etc..) were 
set definitively. “Processing” is a software that exploits the bases of Arduino 
software and it allows the implementation of control interface; in this work, 
this was useful when it was necessary to configure and to control a device in 
real-time."
"
In this thesis, a code developed using the Arduino software was designed to 
allow the operation of the bioreactor during the 4 weeks of cell culture, this 
code implemented three operation methods (“Forward”, “Backward” and 
“Pulse”) at speeds of 170 svm."
In particular, the “Forward” and “Backward” methods allowed the propeller 
respectively a clockwise and couterclockwise, while the “Pulse” method 
allowed rotations very rapid (with a period of 150ms) alternately clockwise 
and counterclockwise. “Forward” and “Backward” methods were needed to 
allow the creation of two alternate streams, in order to improve the cell load 
above and internally to scaffolds. “Pulse” method was needed to maintain 
scaffolds in suspension and to create a light flow inside them."
A code, developed using the processing software, was realized for the 
creation of a user interface that would allow different operations in real-time 
during the use of the bioreactor."
"
"
"
"
"
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2.1.2 Interface!"
The user interface (Figure 12), as already mentioned above, allowed to 
operate on the device in real-time. Its implementation was primarily useful for 
testing different phases of the bioreactor"
"
  "
Figure 12 - User interface, daily program"
"
The main available functions were:"
"
• Set a default program (daily)"
"
• Set a custom program"
"
Through the daily program, the bioreactor, worked alternating the phases of 
“Forward”, “Backward” and “Pulse”, for a time and speed defined by the 
user; “Forward” and “Backward” speeds were the same that were utilized for 
“Pulse” phase; it was possible to define a “Pause” between the phases; this 
feature was helpful to use the device for short time (e.g. during a normal 
working day)."
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The custom program (Figure 13) allowed to setting the various phases in 
even greater detail, and this feature was helpful to use the device for long 
periods of time (e.g. 2-3 days or weeks)."
"
  "
Figure 13 - User Interface, Custom Program"
"
Finally for both functions, it was possible to extract a "Command 
History" (Figure 14) that was useful, for example, to check if the bioreactor 
had actually carried out, on schedule, all the set phases and then to monitor 
if any anomaly was intervened."
"
! ""
Figure 14 - Example of Command History""
"
"
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2.2 Computational Fluid Dynamic Modeling!"
The fluid dynamics is the part of mechanics that studies the motion of bodies 
within the fluids flowing. If a liquid flows in a pipe then it will define subject to 
an internal motion; if a body moves in a liquid this is called external motion. "
In the field of fluid dynamics it is also necessary, given the numerous 
references, a brief definition of fluid that is defined as a substance whose 
molecules are so few adherents that can slide freely over each other, or they 
may move away from each other indefinitely. It is possible to divide fluids in 
two classes:"
AERIFORMS: when the matter, consisting of molecules, tends to occupy the 
entire available volume, compressible"
FLUIDS: liquid substances, having a proper mass and volume, assume the 
shape of the vessel that contains them, incompressible"
Therefore there are two possible situations:"
"
• Motion of fluids with the hypothesis of constant density (d), then 
incompressible fluid""
• Motion of bodies inside of the fluids, taking into account of the resultant of 
all forces acting on the body, to study the behavior of the concerned body 
(drag force)""
"
2.2.1 Viscosity!"
To talk about motion of a fluid within a body, it is also necessary to introduce 
the concept of viscosity, before in a particular case and then generalizing the 
definition, starting to Newton's law. "
The viscosity is defined as the set of tangential forces between the surface 
and the fluid and between states of different fluid and it is opposed to the 
motion of these fluids respect to the surface, with velocity u (no constant)."
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  "
Figure 15 - Speed of a fluid in motion respect to a firm surface"
In the graph, it is possible to note that, given a fluid in relative motion, 
respect to the solid surface, if a normal to the surface is plotted, after a 
certain interval of time, it is possible to observe the situation of the motion 
itself, which represents the speed of a fluid in motion, respect to a firm 
surface."
The particle in contact with the solid surface has not moved, so it is in the 
case of adherence, in fact in all fluids, the particles in direct contact with the 
solid boundaries do not flow, respect to same boundary."
Newton's law, relative to the fluids in motion on solid surfaces, binds 
tensions that are created with the velocity gradient of the fluid, through the 
constant of viscosity μ"
! """
τ is directed in the opposite direction respect to motion, along the x direction 
on the normal surface to y (in descending toward) and it is measured in 
Pascal [Pa]."
"
μ is called viscosity characterizing each fluid. "
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It also defines the kinematic viscosity ratio"
  "
with μ=dynamic viscosity and ρ=fluid density"
The viscosity is not constant but it varies with temperature: in fact, increasing 
the temperature, the viscosity decreases, as it is possible to see in the 
following graphs"
     "
Figure 16 - The viscosity decreases with increasing temperature"
"
"
"
"
"
"
"
  
 
 
 Misura viscosità nei fluidi:
Viscosimetro a rotazione
 
Dato un cilindro cavo, al cui interno ad una temperatura T = costante è contenuto il liquido in esame, ed
un secondo cilindro posto in rotazione intorno al suo asse da un momento motore ,che si misura in
Newton*metro [N*m] , ad opera di un motorino elettrico. Tarando il cilindro interno con due tacche ,una
per il livello 1 e l’altra per il livello 2 , dovrò misurare la differenza tra momento motore necessario a
produrre la rotazione del cilindro interno quando il livello del liquido è in 1 e quando è in 2; la velocità di
rotazione dovrà essere la medesima (fig.2).
 
Dalla differenza dei due momenti potrò risalire alla viscosità
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2.2.2 Model!"
It is supposed to consider the motion of a fluid inside a tube of radius r with 
velocity u. By convention, this situation is studied on a volume element of the 
fluid with the following characteristics"
! "
Figure 17 - Forces acting on the volume fluid element""
L = length of considered volume element "
D = diameter of the element"
r = D/2 = radius of the element "
τ = shear stress that curbs the fluid element in motion"
Considering an equation that expresses the balance of the forces acting on 
the fluid element, it is possible to write: "
!     (1)""
p1, p2 = pressures acting on the fluid element"
A = area of the base circumference of the fluid element"
"
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Now calculating"
!   (2)""
And replacing the (2) in the (1) , it is possible to write:"
! "
"
! "
"
! "
"
! "
"
! "
The last obtained equation represents the velocity profile of the fluid in the 
tube. It is possible then to affirm:"
  "
"
! "
"
"
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Then:"
"
!
! "
! "
! "
! "
"
Ultimately:"
!  "
"
! "
"
"
"
"
"
"
"
"
"
"
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2.2.3 Pressure in the Bioreactor!"
In order to know the stresses that would have occurred on the cells, 
stimulating them mechanically, it was assumed to approximate the scaffold 
(small, light, very porous, made in titanium) as an element of the fluid with 
the following characteristics"
"
   "
  "
  "
   ! "
where in particular the speed (w) was extrapolated, in first approximation, by 
measuring the distance covered by the scaffold and the number of times that 
this has covered it in one second."
"
          "
A                                                                                              B!
Figure 18 - A) Simulation of the flow circulating inside the bioreactor; B) Detail of the flow, at 
the height of scaffolds area, where the pressure was calculating"
"
Then starting from"
"
  "
"
"
"
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The pressure, acting on each scaffold, was"
"
  "
"
This parameter was very important in order to test if use of the bioreactor, 
improved or not the growth of the mineralized matrix. In fact, studies focused 
on the effects of fluid shear on osteoblastic differentiation have shown that 
shear stress affects osteogenic signal expression of mesenchymal stem 
cells [54-59]."
"
"
2.3 Stem Cell Culture!"
In this work hES-MP (human Embryonic Stem Cells-Mesenchymal 
Progenitor) were used. Human embryonic derived mesenchymal progenitor 
cells are cells that belong to the cell line hES-MP002.5, that was developed 
by Cellartis in Gothenburg, Sweden, 2009. These cells have been described 
to have high resemblance to primary adult mesenchymal stem cells (MSC) in 
terms of proliferation and differentiation. Handling and culture of hES-MP 
cells and MSC is almost the same but hES-MP cells require gelatin coating 
of the growth surface prior to seeding."
To obtain a single cell suspension via trypsination of adherent cell cultures in 
monolayer, some equipment and procedures were necessary (see Appendix 
A)."
"
"
2.3.1 Counting Cells!"
Knowing the cell concentration was an important step for subsequent 
seeding cell. Cell concentration of viable cells in a solution was determined 
using hemocytometer."
Hemocytometer is a counting chamber made of glass especially designed 
for cell counting. The chamber has two counting grids that are each put 
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together with 9 “big“ squares that are further dived into 16 smaller squares. A 
cover slide is placed on top of the chamber and a sample of the cell solution 
placed under the cover slide on top of the grids. Each of the 9 bigger 
squares chambers has a surface area of 0,1 mm2 and depth of 0,1 mm. The 
volume of liquid under the cover slide is thus 0,9 mm3."
"
  "
Figure 19 - Detail of Hemocytometer"
"
A sample of the cell solution is stained with tryphan blue stain before 
counting. Cells that are live and viable will not take up the stain but dead 
cells and cell debris will stain blue and should be excluded from the count. 
Procedure to counting cells was described in Appendix B."
"
"
2.3.2 Scaffold Coating Preparation!"
Coating porous titanium scaffolds with fibronectin, is an important step for 
better cell attachment after subsequent cell seeding."
For scaffolds coating preparation, 6 scaffolds were used, 3 scaffolds for 
static culture and 3 scaffolds for bioreactor culture; 4 hours (+ overnight 
incubation), some equipment and procedures were necessary (see 
Appendix C)."
"
"
2.3.3 Static and Bioreactor Culture!"
Bone metabolism is a complex process that involves the resorption of 
existing bone by osteoclasts and the subsequent formation of a new bone 
matrix by osteoblasts. "
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1. Purpose 
Determining cell concentration viable cells in a solution using hemocytometer 
2. Principles and background 
Hemocytometer is a counting chamber made of glass especially designed for cell counting. The 
chamber has two counting grids that are each put together with 9 “big“  squares that are further 
dived into 16 smaller squares. A cover slide is placed on top of the chamber and a sample of the 
cell solution placed under the cover slide on top of the grids. Each of the 9 bigger squares has a 
surface area of 0,1 mm2 and depth of 0,1 mm. The volume of liquid under the cover slide is thus 
0,9 mm3. 
 
 
 
A sample of the cell solution is stained with tryphan blue stain before counting. Cells that are live 
and viable will not take up the stain but dead cells and cell debris will stain blue and should be 
excluded from the count. 
3. Performance specifications 
Time required: 15 min 
Density: Maximum 100 cells per large square (dilute if more) 
 
4. Resources 
 
4.1. Reagents 
 
Counting cells with hemocytometer 
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To start the Cell Culture 6 porous titanium scaffolds (previously coated with 
fibronectin, Figure) and following equipment and procedures were used and 
described in Appendix D. In particular, 3 scaffolds were used for Static 
Culture and 3 for Culture in Bioreactor."
"
  "
Figure 20 - Scaffolds coated with fibronectin, ready to start the static and bioreactor cell 
culture"
"
Both cultures were incubated at 37 °C in a humidified atmosphere containing 
95% air and 5% CO2. Differentiation, in bone tissue, was induced through 
the addition of Ascorbic Acid (Ascorbic Acid γ- irradiated, Sigma) and β-
Glycerophosphate (Glycerol 2-phospate disodium salt hydrate, Sigma) to the 
growth medium containing Fetal Bovine Serum (FBS) and D-MEM 
(Dulbecco's Modified Eagle Medium, Gibco BRL). This solution was replaced 
every 7 days. "
"
"
2.4 Data Acquisition!"
3D modeling programs such as Mimics (Materialize, Belgium), Velocity and 
Anatomics, stack the 2D maps to create 3D models, without these programs, 
visualization and analysis would have been impossible. As computation is 
inherent in this technique, the selection of software and hardware facilities 
would influence the efficiency and effectiveness of this radiographical 
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assessment. There are associated concerns despite of the numerous 
advantages of using microCT."
In this work 3D Models of 3 porous titanium scaffold maintained in static 
culture and of 3 porous titanium scaffold maintained in bioreactor culture 
were obtained by using μCT (phoenix|x-ray Systems, nanotom s, GE, Figure 
21.A)."
"
          "
A                                                                                       B!
Figure 21 - A) MicroCT system (phoenix|x-ray Systems, nanotom s, GE); B) Detail of the 
acquisition area"
"
A μCT starts out by recording 2D-X-ray images of a sample. In the 
acquisition system a cone beam is used. In the process, the tube generates 
radiation which is partly absorbed by the sample. The number of transmitted 
photons is measured with a 2D detector. The detector integrates the 
radiation and transforms it into a digital image in order to save it on the 
computer‘s hard disk. The sample is placed on a rotating platform. The 
rotation is effected with motors. During recording, the sample is rotated step 
by step and one projection is recorded with every step. If too few projections 
are recorded, the quality of the reconstructed volume deteriorates and 
typical artefacts become visible. The imaging chain includes a detector to 
measure the intensity of the transmitted X-rays and acquisition electronics 
which digitize the detector signals and send them to a computer for 
reconstruction. The individual modules, X-ray control, CNC and data 
acquisition are controlled by the datos|x - acquisition program. The pixel size 
was 4.95μm, which seemed appropriate to image porous titanium scaffolds. 
Tube voltage was set to 120kV, current to 100 μA. Tube mode was set to 2. 
For each sample, 1080 radiographic images (or projections) with 2304 × 
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2304 pixels were acquired at different angles of view between 0° and 180°. 
According to the design of the experiment the total acquisition time was 
approximately 180 minutes for sample."
"
After radiographic data acquisition, CT reconstruction was performed by 
means of a 3D filtered back-projection algorithm to retrieve the 3D scaffold 
structure image. For each sample, the reconstruction was limited to a 1250 × 
1250 × 1000 voxel subvolume, which corresponded to a volume scaffold and 
included the background. The reconstruction time was approximately 10 
minutes per sample. The program datos|x – reconstruction calculates a 
volume model from the recorded images of the sample. For this purpose, 
datos|x – reconstruction uses an optimized Feldkamp-algorithm resulting in 
an extraordinary reconstruction quality. This work was conducted in the 
Innovation Center in Iceland (http://www.nmi.is/)."
"
"
2.5 Data Analysis!"
The scaffold structure was porous and had a cylindrical shape with diameter 
approximately of 5-5,5 mm and height of 3-3,5 mm"
A detailed volumetric representation was obtained by scanning the scaffolds 
with slice distance and pixels size of 4,5 μm, each slice was represented 
with a matrix of 1250 x 1250 pixels. Every data set contained between 1000 
and 1500 DICOM files, which summed up to a considerable amount of data 
for each scaffold (2 to 4 GB)."
After this, the data were imported into special software called “Mimics” where 
3D reconstruction, modeling and advance segmentation was performed."
Generally, in computer vision, segmentation refers to the process of 
partitioning a digital image into multiple regions (sets of pixels) and it 
produce a binary mask image which fulfills the segmentation criteria [60]. 
In the analysis of an image region is essential to distinguish between the 
region of interest and "the rest”. This latter group is also referred to as the 
“background”. The techniques used to find the objects of interest are usually 
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referred to as segmentation techniques: segmenting the foreground from 
background. Any segmentation result is a set of pixels that are related to 
each other in some sense, that is they belong to the same class (e.g. tissue 
class or an object in an image). This set of pixel is usually called 
segmentation mask or simply mask. Each pixel contains information which is 
represented through the gray value (GV). By grouping together gray values 
according to certain criteria (Thresholding), the image data can be 
segmented and the 3-Dimensional object created. An optimal thresholding is 
very important in order to obtain correct result from data analysis on the 
binarized data set [61]."
The threshold was set to visualize the porous titanium scaffold; this threshold 
was represented in the GV interval [about 20000-30000]. "
The 3D Model reconstruction can be see in the following Figure 22"
"
!  
Figure 22 - Different views and 3D Model of porous titanium scaffold"
"
To facilitate the data processing and to assess the GV homogeneity along 
the scaffold, every porous titanium scaffold was divided in segments (Figure 
23), generating 20 “sub-scaffold” masks, 10 for the scaffold surface and 10 
for the scaffold internal area. In this way 30 specimens coming from surface 
and 30 specimens coming from inside of scaffolds maintained in static 
culture were obtained. In a similar way 30 specimens coming from surface 
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and 30 specimens coming from inside of scaffolds maintained in bioreactor 
culture were obtained. "
"
!  
Figure 23 - Segmentation of titanium scaffold"
"
To quantify on the scaffolds the extracellular matrix mineralization changes, 
GV distribution changes were analyzed. Therefore, starting to the GV 
distribution, the Gradient Distribution was calculated to visualize in 3D the 
extracellular matrix changes on the scaffolds; to do this a following criteria 
was applied."
Consider a cross section of the μCT data in which the scaffold composition 
was given by a scalar field GV, associated to each pixel, then to each point 
(x,y,z) of the mask. This point was displayed as "GV (x,y,z)". At each pixel in 
the image, the gradient of GV in that point showed the direction of most 
rapid changes of the GV in the scaffold. The magnitude of the gradient was 
determinate how fast the GV increased in that direction. To calculate and to 
display the Gradient Distribution, from the segmented scaffold, an algorithm 
was developed in Matlab (Matworks Inc). 
First, the gradients were computed using a central finite difference 
approximation for each voxel. So for each point f(x, y, z), each gradient 
component was found by:"
"
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! "
! "
! "
"
Where hx, hy and hz were the separation between the adjacent points in x, y 
and z directions, respectively [62]. "
"
"
"
"
"
"
"
"
"
"
"
"
"
"
"
"
"
"
"
"
"
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3. Results!"
3.1 Bone Tissue Formation!"
The static and bioreactor cell cultures foresaw a running time of four weeks 
for a good cell growth. In the third week of culture, an interruption was 
necessary due to a bacterial infection in a bioreactor."
"
There are many possible reasons why the bioreactor might have gotten 
infected. Some factors were more likely than others and included:"
"
• Underlying infection since the bioreactor assembly !
This was without a doubt the most risky stage to get infected due to the 
many components that needed to be handled and putted into the bioreactor."
"
• Infection during feeding!
The fact that the whole bioreactor needed to be removed from the incubator 
to change the media was undesirable and increased the risk of infection 
each time. The lid of the bioreactor needed to be removed each time, leaving 
large surface area exposed and vulnerable for short time, during the change. 
Furthermore, the propeller that went right into the culture media, needed to 
be removed from the bioreactor as well (since it was attached to the lid) and 
putted aside giving it enough time to catch something before it was returned 
to the bioreactor.!
"
• Infection during transfer between the hood and the incubator!
The junction between the motor and the lid was not tight. The glue was not 
able to seal it securely and sticky tape had to be used to stabilize the motor 
when it was shaking. Therefore the infection might originate from the 
transfer."
"
"
"
"
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• Infection from the incubator"
Possible but unlikely. Neither the static cultures or any other cultures in the 
incubator at the same time got infected."
"
During a long term culture even the smallest infection can become 
something big, since the cell culture conditions are obviously the best 
conditions for infectious organisms such as fungi as well as for cells. Even 
though the best working procedures were applied there were so many 
factors that were hard to control and so obtain an infection was probable. "
"
After 3 weeks of culture, then, cells on scaffolds were fixed in Formalin. The 
scaffolds were washed several times with PBS afterwards to remove 
formalin and then were used for μCT-scanned."
"
"
3.2 Static and Bioreactor Culture Comparison !"
After the μCT scanning 3D Model of each scaffold was created through the 
software “Mimics” (see section 2.6)."
"
              "
A                                                                              B!
Figure 24 - A) Scaffolds during μCT scanning; B) 3D Model of Scaffold"
"
"
"
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Subsequently, each model was sectioned in order to obtain 10 specimens 
taken from the surface and 10 specimens taken from the inside of it. In this 
way were obtained:"
"
• for scaffolds maintained in static culture, 30 specimens coming from the 
surface and 30 specimens coming from inside"
"
• for scaffolds maintained in the bioreactor, 30 specimens coming from the 
surface and 30 specimens coming from inside  "
"
Then, 120 specimens were obtained. An analysis of specimens was carried 
out observing the Gray Value Gradient Distribution and performing a 
statistical analysis by T-Test."
"
The results of these two studies were useful to understand if, in scaffolds 
maintained within the bioreactor, there was a greater mineralization of the 
extracellular matrix respect to the scaffolds maintained in the classical static 
culture."
"
"
"
""""""""""""""""
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3.2.1 Gray Values Gradient Distribution!"
The specimens obtained by the sectioning of the scaffolds was processed in 
order to obtain the Gray Value Gradient Distribution (see section 2.5). A 
specimens coming from an empty scaffold was used as a tester. Then a 
comparison was performed"
"
  "
Figure 25 - Comparison between sample coming from surface of the scaffolds"
 "
  "
Figure 26 - Comparison between sample coming from inside of the scaffolds"
"
In both figures, it was possible to note that three groups of specimens 
(empty, static, bioreactor) had similar GV Gradient Distribution (top in 
figures). In particular, the center of smaller Gaussian distribution had a 
tendency to increase respectively in the specimens. "
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The same results were observed in the 3D visualization of the GV Gradient 
Distribution (bottom in figures); gradient intensity was coded with colors, in 
blue was displayed low gradient voxels and in red was displayed high 
gradient voxels."
Changes of this distribution could indicate possible structural changes in the 
scaffolds maintained in the bioreactor."
"
"
3.2.2 Statistical Analysis!"
In order to understand, in a statistical way, if the use of the bioreactor had 
actually improved the structural changes, the t-test was used to perform: 
three different types of comparison between scaffolds maintained in static 
culture and scaffolds maintained in bioreactor culture; two different types of 
comparison between samples of scaffolds coming from surface and inside of 
the static and bioreactor culture. "
"
"
• Comparison between Static and Bioreactor Culture considering 60 
specimens (30 Static, 30 Bioreactor) taken from the surface of scaffolds of 
respective cultures"
"
Table 3 - T-Test between surface samples"
"
"
"
"
"
"
"
Cell 
Culture Mean STD Sp t0 t0.05,58 = 1.671
Static 23034 75.075
1432.5 11.627 H1
Bioreactor 27335 1430.5
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• Comparison between Static and Bioreactor Culture considering 60 
specimens (30 Static, 30 Bioreactor) taken from the inside of scaffolds of 
respective cultures"
"
Table 4 - T-Test between inside samples"
"
"
• Comparison between Static and Bioreactor Culture considering 120 
specimens (60 Static, 60 Bioreactor) taken from the scaffolds of respective 
cultures"
"
Table 5 - T-Test between whole samples"
"
"
• Comparison between Static and Bioreactor Culture considering 60 
samples, 30 taken from the surface and 30 taken from the inside of 
scaffolds in static culture"
"
Table 6 - T-Test between surface and inside samples of static culture"
"
"
Cell 
Culture Mean STD Sp t0 t0.05,58 = 1.671
Static 22708 151.75
1357.8 12.543 H1
Bioreactor 27105 1349.3
Cell Culture Mean STD Sp t0 t0.05,118 = 1.658
Static 22871 113.29
1393.4 17.093 H1
Bioreactor 27220 1388.8
Static!
Cell 
Culture
Mean STD Sp t0 t0.05,58 = 1.671
Surface 23034 75.075
169.31 7.4649 H1
Inside 22708 151.75
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• Comparison between Static and Bioreactor Culture considering 60 
samples, 30 taken from the surface and 30 taken from the inside of 
scaffolds in bioreactor culture"
"
Table 7 - T-Test between surface and inside samples of bioreactor culture"
"
"
The results of T-Test show that in first three comparisons, the hypothesis H1 
could be accepted, namely, the use of the bioreactor had made  significant 
improvements to the structural changes in the scaffolds contained in it. 
Furthermore, the hypothesis H1 could be accepted also for the T-Test 
performed between the samples taken from the surface and inside of static 
culture, demonstrating that the structural changes occurred in non 
homogenous way (likely more in the surface than in the inside); this result 
could not be observed with the analysis of GV Gradient Distribution. Indeed, 
in the T-Test performed between the samples taken from surface and inside 
of bioreactor culture, the hypothesis H0 could be accepted, demonstrating 
that the structural changes occurred in homogenous way."
"
"
"
"
"
"
"
"
"
"
"
"
Bioreactor!
Cell 
Culture
Mean STD Sp t0 t0.05,58 = 1.671
Surface 27335 1430.5
1966.5 452 H0
Inside 27106 1349.3
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4. Discussion!"
In most clinical cases, crucial bone defects are impossible to cure due to a 
big gap in the bone. These cases are caused for example by cancer, 
accidents or serious infections and many other sicknesses. Healing of these 
big gaps naturally is often hard or impossible. In those cases, bone grafting 
is often implemented. There are two kinds of methods which are used for 
bone grafting. These are “autografting" and “allografting”. In case of 
“autografting”, the injured bone is replaced with a bone taken from the 
patient’s own body. If the gap is so big that “autografting” is not possible, the 
“allografting” approach is done and the injured bone is replaced with a bone 
from a cadaver. Both these methods have disadvantages: in case of 
“autografting”, there are medical complications after surgery; in case of 
“allografting”, a risk of immune response and possibility of infection. To solve 
this problem, researchers have been dealing with tissue engineering to try to 
create a bone tissue. Bone tissue strategy is mainly about creating or form 
bone tissue by cell expansion and differentiation on 3-dimensional scaffolds. 
The 3-dimensional scaffolds give the tissues physical form and a support for 
the new bone tissue formation. Studies, made in vivo and in vitro, show that 
physical forces such as fluid flow and mechanical loading stimulate bone 
factor metabolism. The mechanical stimulation can inspire cells to create an 
extracellular matrix in a shorter time period and also in a more 
homogeneous manner than in static culture."
"
To create the most likely biological environment for cells, a perfusion 
bioreactor was designed and tested. The main aim of this bioreactor was:"
"
• To get nutrition to cells everywhere on the 3-dimensional scaffolds"
"
• To provide mechanical stimulation that could inspire cells to create an 
extracellular matrix in a shorter time period"
"
• To obtain a more homogeneous growth than in static culture"
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To calculate the mechanical stimulation on scaffolds in bioreactor, a 
theoretical model was used, with the appropriate approximations, and 
comparable results with the values present in the literature [49] were 
obtained. During cell culture, to improve extracellular matrix growth and 
calcium deposition, six porous titanium scaffolds were used (three in static 
culture and three in bioreactor culture); they were seeded with osteoblastic 
progenitor cells (hES-MP) and perfused with osteogenic medium. After three 
weeks, the culture was interrupted and scaffolds were fixed in formalina and 
afterwards washed several times with PBS to remove it and to obtain 
scaffolds usable for scanning by μCT."
For tissue engineering applications, microCT imaging may provide an 
efficient, non destructive tool to quantitatively measure the amount and 
distribution of mineralized matrix formation throughout 3D construct in vitro 
and in vivo [63]."
The tomographic image data obtained, in DICOM format, were imported into 
the “Mimics” software and they were appropriately segmented, in order to 
obtain, from each of two type of culture, 30 samples coming from surface 
and 30 samples coming from inside of the scaffolds. A Matlab script was 
implemented to compare tomographic data relative to scaffolds in different 
conditions (three maintained in static culture and three in bioreactor culture, 
compared with one empty as tester). The script highlighted the evolution of 
the GV gradient in segmented scaffolds and from it a GV Gradient 
Distribution was obtained. All diagrams showed two Gaussian distribution; 
one big and one small. In particular, the center of smaller Gaussian 
distribution had a tendency to increase, greater in bioreactor samples 
respect to the static samples. Same results were observed in the 3D 
visualization of the GV Gradient Distribution, where the intensity of color 
changed greater in bioreactor samples. Changes of this distribution could 
indicate possible structural changes in scaffolds maintained in the bioreactor."
To confirm these results, statistical analysis was performed by five T-Test 
confirming that: "
"
• Use of the bioreactor had made significant improvements to the structural 
changes in scaffolds maintained in it"
"
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• In the specimens taken from the surface and inside of static culture, 
structural changes occurred in non homogenous way (likely more in the 
surface than in the inside) and this result could not be observed with the 
analysis of GV Gradient Distribution"
"
• In the samples taken from surface and inside of bioreactor culture, the 
structural changes occurred in homogenous way"
"
• The results coming from use of GV Gradient Distribution was statistically 
significant"
"
Although good results were obtained, limitations are still present due to:"
"
• The high number of parts to be manipulated to assemble the bioreactor "
"
• The replacement of the media non-automated "
"
• The lack of sensors useful for monitoring parameters such as the speed of 
the flow"
"
• The limited number of scaffolds analyzed"
"
In particular, the first two limitations are those that increase the risk of 
infection; the other limitations, instead, if resolved would improve the quality 
of results."
"
"
4.1 Future Directions!"
The studies, coming from use of bioreactor discussed in this thesis, will be 
used to design a new version that will make it possible to prepare and test 
more than 20 scaffolds at the same time making it possible to further analyze 
the quality of the differentiation using molecular and histochemical 
methodology. "
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To do this, different changing should be applied in order to improve the 
structure and usability of the device. Possible changing might be: adding 
useful tools to monitoring parameters as e.g. the flow velocity, decrease 
number of parts to manipulate during the device assembly, automate the 
media replacing. In particular, these last two change might help to decrease 
the bacteria infection risk."
"""""""""""""""""""""""""""""""""""""""""""""
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5. Conclusion!"
Bioreactors have been shown to be used to improve cell seeding efficiency 
[64-66], cell proliferation [67-69], and mesenchymal stem cell osteoblastic 
differentiation [70-77]. In addition, to enhancing differentiation and 
proliferation, perhaps the most notable contribution of bioreactor systems to 
a bone tissue engineering strategy is the possibility of automation. A 
clinically relevant strategy must greatly minimize the risk of contamination 
from bacteria and other cells, reduce labor intensity, and reduce costs 
associated with in vitro cell culture. Bioreactor systems have the potential to 
minimize all of these aspects through automated cell culture. "
Furthermore, scaffolds with stem cells obtained through the use of 
bioreactors, at the end of the culture period, might be implanted into the 
patients, affected by cancer, accidents or of serious infections and many 
other sicknesses, in order to replace bone defects."
"""""""""""""""""""""""""""""
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Appendixes!"
Appendix A!"
Equipment!
Table 1 - Reagents used for harvesting stems cells"
"
Table 2 - Components used for harvesting stems cells"
"
Table 3 - Devices used for harvesting stems cells"
"
Reagent Manifacturer
DMEM F12 + Glutamax medium Gibco, Grand Island, NY, USA
Penicillin-Streptomycin Gibco
Fetal Bovine Serum!
(heat inactivated or MSC !
screened)
Gibco
10% Platelet lysate media Bloodbank, Reykjavik, Iceland
PBS Gibco
Confluent hES-MP cells in 
monolayer Cellartis, Gothenburg, Sweden
0.1% Gelatin Sigma Aldrich, St. Louis, MO, USA
0.25% Trypsin Gibco
Component Manifacturer
75cm cell culture flasks Nunc, Penfield, NY, USA
Tubes (15 and 50 ml) Falcon, Franklin Lakes, NJ, USA
Pipettes and tips Gilson, Middleton, WI, USA
Device Manifacturer
Centrifuge Thermo Scientific, Vantaa, Finland
Incubator (5% CO2, 95% H2O) N/A
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Protective equipment should be worn while handling the components of this 
assay. Wear lab coat, protective gloves and safety googles at all times."
hES-MP002.5 are cells of human origin. Same procedures that apply to 
other tissue of human origin such as blood should be followed.!
"
 Table 4 - Precautions for the components used during harvesting stems cells"
"
Procedure!
"
Preparation of solutions!
"
For the preparation of cell culture media, the following protocols was applied:"
"
• Preparation of Culture media with 10% Platelet lysate in DMEM F12 
+glutamax."
• Preparation of Culture media with 10% FBS in DMEM F12 +glutamax."
"
"
"
Component Storage Hazards and Precautions
DMEM F12 +glutamax 4-8°C Not dangerous
Penicillin 
Streptomycin -20°C
Danger!
Skin corrosion, serious 
eyes damage, 
respiratory and skin 
sensitization, 
reproductive toxicity
Fetal bovine serum -20°C Not dangerous
Platelet lysate -20°C Not dangerous
Sterile Gelatin 4-8°C Not dangerous
Sterile PBS RT Not dangerous
Trypsin -20°C Not dangerous
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Preparation of 0.1% gelatin solution!
"
• Bringing 2% gelatin stock solution to room temperature. "
• Working under sterile conditions in a clean hood with the fan on. "
• In a 50 ml tube mixing 47,5 ml sterile H2O with 2,5 ml 2% gelatin. "
• Storing at 4-8°C. "
"
"
Coating cell culture flasks and preparation !
"
• Blending media or obtaining already prepared media  
o Making sure that media has 0.1% Penicillin streptomycin and 10% 
supplement (either   bbPL or FBS) 
o If using platelet lysates (PL) making sure that media has 4IU/ml of 
heparin"
• Bringing the media and the trypsin to 37°C in the shaking plate incubator "
• If preparing cells to be reseeded, working sterile and add 5 ml of 0.1% 
gelatin solution to a sterile 75cm2 cell culture flask (67μl/cm2) or other 
culture vessel of your choice. "
• Close the flask, allowing the gelatin to completely float over the culture 
surface and keeping at 4-8°C for at least 30 min. "
• Making sure that your flask is carefully labeled with your name, date, cell 
type, media type and passage number.  
"
"
Harvesting cells!
 !
• Preparing the laminar flow hood with clean o Pipettes and tips"
   o Waste container with chlorinated water o Empty lab tubes  
   o Reagents to be used"
• Obtaining the cell culture from the incubator and placing inside the hood. "
• Loosening the cap and pouring the media into the waste container. "
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• Transfering 5 ml sterile PBS (67μl/cm2) into the cell culture flask. Close the 
flask and allowing the PBS to float over the culture surface by rocking the 
flask gently. "
   o This will wash excess media from the culture flask and ensure better   "
        effectiveness of the trypsin in next steps."
• Pouring the PBS off and then putting 5 ml of warmed Trypsin into the flask. "
• Close the flask and putting it into the incubator for 5 min "
   o The trypsin, as a digestive enzyme, will release the cells from the plastic "
        surface."
  o When the cells are released they will appear small, round and bright in 
the microscope and float around creating a “snow storm” impression."
   o In this step the cells should be monitored carefully since 
prolonged trypsin digestion can harm the cells. When the cells are 
released proceed immediately to next step.!
• Returning the cell culture flask into the hood and adding 5 ml of pre-
warmed media into the flask."
   o The supplemented media will help neutralize the trypsin and stop the 
digestion."
• With the aid of a pipettboy, using the cell solution inside the flask to wash 
the culture surface and then transferring the solution to a 15 ml tube. "
• Centrifugating for 5 min at 1750 rpm. "
• Pouring of the supernatant into the waste container and resuspending the 
cells in 1 ml culture media. "
   o If the cell solution is dense, like when combining cells from many culture 
flasks into a single tube, resuspend the cells in as many ml as the number of 
culture flasks. 1 culture flask = 1 ml."
• Proceed to cell counting. Seeing the following protocol:"
   o Counting cells with hemocytometer"
• When the number of cells has been obtained they can be reseeded, frozen 
or used for experimentation. "
• If reseeding, using gelatin coated culture flask and using 5500 cells/cm2 
seeding density. "
"
"
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Precautions!
"
Use sterile working techniques without exceptions when handling cells 
for culture.!
This includes cleaning everything with ethanol prior to entering the hood, 
including gloved hands."
Always use a clean water-bath. Mark the medium bottle as supplemented 
and write your name and date (as for all solutions you work with). Always 
take the volume you expect to need from the a stock bottle for media or PBS 
and place in a different sterile container (like 50 ml plastic tubes) before 
continuing work. This is to prevent contaminating your medium bottle. Do not 
spray ethanol on culture flasks because the cells are sensitive to ethanol."
"
"
"
"
"
"
"
"
"
"
"
"
"
"
"
"
"""
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Appendix B!"
Equipment!
"
Table 1 - Reagents used for counting cells"
"
Table 2 - Components used for counting cells"
"
Table 3 - Devices used for counting cells"
"
Protective equipment should be worn while handling the components of this 
assay. Wear lab coat, protective gloves and safety googles at all times."
"
Reagent Manifacturer
Trypan Blue Gibco, Grand Island, NY, USA
PBS Gibco
Cell solution of unknown 
concentration
Component Manifacturer
Microtubes Sarstedt, Nümbrech, Germany
Pipettes and tips Gilson, Middleton, WI, USA
Device Type Producer
Hemacytometer Neubauer Assistant, Munich, Germany
Cell counter N/A
Microscope
Lumenera, Capella 
court, Ottawa, ON, 
Canada
Calculator N/A
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Table 4 - Precautions for the components used during counting cells"
"
Procedure!
"
Preparation of stained cell solution!
• To a microtube adding  
o 50μl Trypan Blue"
   o 30 μl PBS"
   o 20μl Cell solution. "
• Mixing well"
• Note! Never bring your cell solution outside of the cell hood. 
o You want your cell solution to remain sterile. Simply transfer a sample of 
the cell solution into the staining solution inside the hood under sterile 
operating procedures.  "
• Afterwards, the staining solution containing the cell sample can be brought 
outside the hood."
"
"
Cell Counting!
"
• Preparing the counting chamber  
o Making sure the counting surface of the Neubauer hemacytometer is 
clean  
o Placing the cover slide on top of the counting surface  
   o The cover slide will stay in place on the counting chamber via capillary  "
Component Storage Hazards and Precautions
Trypan Blue RT
Danger!"
May cause cancer 
Suspected of causing 
genetic defects "
Suspected of damaging 
fertility or the unborn 
child
PBS RT Not dangerous
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          force. Trying to breathe gently on the glass and then placing it   "
          immediately on the counting chamber. "
• With a pipette transferring a small amount of the cell solution into the 
hemocytometer by placing the tip at the end of the cover slide and gently 
allowing the solution to be drawn under cover slide until the area is 
covered. Do not overfill. "
• Counting all the cells in the four big corner squares. Excluding cells that 
stain blue. "
• If more than 200 cells are counted per big square, diluting the solution and 
repeating. "
"
Calculation!
• The volume of each square is 1 mm3 or 10-3 cm3. 1 cm3 equals 1 ml so the 
count can be found with the following formula:  
"
Cells/ml = Average count per square * dilution factor * 104 "
" " "
• If the protocol above is followed the total cell count is divided by 4 and the 
dilution factor is 5  
"
  "
 "
• To obtain the total cell count of the original solution, the outcome is simply 
multiplied by the original volume of the solution "
• It’s recommended to count each stained solution few times (2-4 times) and 
mix thoroughly between counts to obtain more accurate results. "
"
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! "
Figure 1 - The figure show in the centre the Microscope, bottom right the cell counter"
"
Precautions!
Use sterile working techniques without exceptions when handling 
materials intended for cell culture.  
This includes cleaning everything with ethanol prior to entering the hood, 
including gloved hands. "
Tryphan blue is a histological dye to stain tissues. Wearing protective gloves 
and safety googles is recommended since both fingers and eyes are 
covered with tissue that you don’t want to stain!"
Wear lab coat, the stain will not wash out of clothes."
"
"
"
"
"
"
"
"
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Appendix C!"
Equipment!
Table 1 - Reagents used for scaffolds preparation"
"
Table 2 - Components used for scaffolds preparation"
"
Table 3 - Devices used for scaffolds preparation"
"
Protective equipment should be worn while handling the components of this 
assay. Wear lab coat and protective gloves."
"
"
Reagent Manifacturer
Fibronectin (5 μg/ml) Sigma Aldrich, St. Louis, MO, USA
PBS Gibco, Grand Island, NY, USA
Cell culture media (e.g. a-MEM, 
DMEM) Gibco
Component Manifacturer
20 ml syringe Braun, Melsungen, DE
Syringe-driven sterifilter Millipore, Billerica, MA, USA
Pipettes and tips Gilson, Middleton, WI, USA
24 well plate – non-tissue treated BD Falcon, Franklin Lakes, NJ, USA
Sterile porous titanium scaffolds Icelandic Innovation Center, Reykjavik, Iceland
Device Type Producer
Warming/shaking 
incubator Unimax 1010
Heidolph, Schwabach, 
DE
Pincett Gibco, Grand Island, NY, USA N/A
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Table 4 - Precautions for the components used during scaffolds preparation"
"""
Procedure (Figure 1)!
"
• Preparing a 5μg/ml fibronectin solution in PBS."
   o 1 ml per scaffold is needed + surpluses for the infiltration step"
• Adding 1 ml of fibronectin solution into a 24 well plate, 1 well per scaffold."
• Opening the syringe and placing the scaffolds in it. "
• Drawing fibronectin solution into the syringe, enough to completely 
submerging the scaffolds in and pushing out any air in the syringe. "
• Attaching a syringe-driven steril filter to the syringe. "
• Putting your finger on the tip of the steril filter and pulling the plunger to 
allow air to be drawn out of the scaffolds. "
• Releasing the plunger and allowing the fibronectin solution to infiltrate the 
scaffolds. "
• Repeating few times, pushing out any air that accumulates in the syringe. "
• When the scaffolds have been thoroughly infiltrated with the fibronectin 
solution, transferring them into the 24 well plate. "
• Covering the scaffolds with a fibronectin solution, using the rest of the 
syringe solution if necessary. "
• Putting on a shaker for 3 hours at 37°C. "
• After incubation, replace the fibronectin solution with cell culture media. "
• Allowing to rest in a culture incubator overnight. "
Component Storage Hazards and Precautions
Cell culture media 4-8°C Not dangerous
Fibronectin -20°C Not dangerous
PBS 22°C Not dangerous
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  "
Figure 1 - Procedure followed to treat the scaffolds with fibronectin"
"
Precautions!
Use sterile working techniques without exceptions when handling 
materials intended for cell culture.  
This includes cleaning everything with ethanol prior to entering the hood, 
including gloved hands. "
"
"
"
"
"
"
"
"
3 
 
x Open the syringe and place the scaffolds in it. 
x Draw fibronectin solution into the syringe, enough to completely submerge the scaffolds 
in and push out any air in the syringe. 
x Attach a syringe-driven sterifilter to the syringe. 
x Put your finger on the tip of the sterifilter and pull the plunger to allow air to be drawn 
out of the scaffolds. 
x Release the plunger  and allow the fibronectin solution to infiltrate the scaffolds. 
x Repeat few times, pushing out any air that accumulates in the syringe. 
x When the scaffolds have been thoroughly infiltrated with the fibronectin solution, 
transfer them into the 24 well plate. 
x Cover the scaffolds with a fibronectin solution, using the rest of the syringe solution if 
necessary. 
x Put on a shaker for 3 hours at 37°C. 
x After incubation, replace the fibronectin solution with cell culture media. 
x Allow to rest in a culture incubator overnight. 
 
 
 
6.1. Quality control 
Use sterile working techniques without exceptions when handling materials intended for cell 
culture.  
This includes cleaning everything with ethanol prior to entering the hood, including gloved 
hands.  
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Appendix D!"
Equipment!
"
Table 1 - Reagents used for cell culture "
"
Table 2 - Components used for cell culture"
"
Table 3 - Devices used for cell culture"
"
Protective equipment should be worn while handling the components of this 
assay. Wear lab coat, protective gloves and safety googles at all times."
"
Procedures!
"
• Obtaining the plate with 6 coated scaffolds in cell culture medium from the 
overnight incubation."
• Removing the scaffolds from the medium and placing in a new 24-well 
plate."
Reagent Manifacturer
Cell culture media (e.g. a-MEM, 
DMEM) Gibco, Grand Island, NY, USA
Cell culture supplement (e.g. FBS, 
hPL)
Cell solution (e.g. MC3TE, MSC or 
hES-MP)
Component Manifacturer
24 well plate – non-tissue treated BD Falcon, Franklin Lakes, NJ, USA
Sterile porous titanium scaffolds Icelandic Innovation Center, Reykjavik, IS
Pipettes and tips Gilson, Middleton, WI, USA
Device Producer
Centrifuge Thermo Scientific, Vantaa, Finland
Incubator (5% CO2, 95% H2O) N/A
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• Allowing the scaffolds to dry for 1 hour at 37°C in the bench top incubator"
• Adjusting your cell solution to 4000 cells/μl (100.000 cells/ 25μl)"
• Obtaining the correct amount of cells needed in a test tube."
    o You need 100.000 cells per scaffold"
• Centrifuging for 5 min at 1750 rpm (545 x g)"
• Discarding the supernatant"
• Resuspending the cells in 25μl of cell culture media for each scaffold."
"
• Seeding 25 μl (100.000 cells) drop by drop on each scaffold and 
incubating in the CO2 incubator for 15 min."
    o Mixing the cell solution well prior to seeding each scaffold.!
• After 15 min, removing the scaffold-plate from the incubator and aspirating 
and reseeding any medium that has leaked from the scaffolds."
• Returning the plate to the incubator for another 15 min."
• Repeating for a total of 4 times."
• At the end of the 4th seeding"
   o Getting 3 of 6 scaffolds and add it into the 3 wells of 24-well plate; after "
       adding 1 ml media for each well."
   o Getting the remaining 3 scaffolds and adding it into the bioreactor; after "
       adding the necessary media."
• Returning to the incubator for culture."
"
"
Precautions!
"
Use sterile working techniques without exceptions when handling cells 
for culture.  
This includes cleaning everything with ethanol prior to entering the hood, 
including gloved hands.  
Mixing the cell solution prior to seeding is important. No blending will result 
in inaccurate seeding density and negatively affect the experiment."
""""
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